Stock Earnings

Question 1

Towa Pharmaceutical Co Ltd'in temel mali tabloları nelerdir?

Accepted Answer

Son mali tabloya (Form-10K) göre, Towa Pharmaceutical Co Ltd'in toplam varlıkları $470,823 olup, net profit $18,986'dir.

Question 2

TWAPF'ün temel finansal oranları nelerdir?

Accepted Answer

Towa Pharmaceutical Co Ltd'in cari oranı 1.57, net kâr marjı 7.31, hisse başına satış $5,273.62'dir.

Question 3

Towa Pharmaceutical Co Ltd'in geliri segment veya coğrafya bazında nasıl dağılıyor?

Accepted Answer

Towa Pharmaceutical Co Ltd largest revenue segment is Pharmaceutical, at a revenue of 259,594,000,000 in the most earnings release.For geography, Japan is the primary market for Towa Pharmaceutical Co Ltd, at a revenue of 206,103,000,000.

Question 4

Towa Pharmaceutical Co Ltd kârlı mı?

Accepted Answer

yes, son mali tablolara göre Towa Pharmaceutical Co Ltd'in net profit $18,986'dir.

Question 5

Towa Pharmaceutical Co Ltd'in herhangi bir yükümlülüğü var mı?

Accepted Answer

yes, Towa Pharmaceutical Co Ltd'in yükümlülüğü 299,198'dir.

Question 6

Towa Pharmaceutical Co Ltd'in tedavüldeki hisse sayısı kaçtır?

Accepted Answer

Towa Pharmaceutical Co Ltd'in toplam tedavüldeki hisse sayısı 49.22'dir.

Breakdown	TTM	03/31/2025	03/31/2024	03/31/2023	03/31/2022	03/31/2021
Revenue	262,177	259,594	227,934	208,859	165,615	154,900
Revenue Growth (YoY)	11%	14%	9%	26%	7%	40%
Cost of Revenue	167,116	164,865	146,551	136,145	95,429	89,448
Gross Profit	95,061	94,729	81,383	72,714	70,186	65,452
Selling, General & Admin	72,284	55,274	50,493	51,934	39,492	34,885
Research & Development	--	16,212	13,242	15,265	11,488	10,642
Operating Expenses	72,285	71,487	63,736	67,200	50,981	45,529
Other Non Operating Income (Expenses)	1,181	1,053	528	906	59	533
Pretax Income	21,706	26,330	24,459	4,605	22,246	18,728
Income Tax Expense	5,701	7,343	8,286	2,404	6,331	4,770
Net Income	16,004	18,986	16,173	2,201	15,914	13,958
Net Income Growth	-5%	17%	635%	-86%	14%	-4%
Shares Outstanding (Diluted)	49.22	49.22	49.22	49.22	50.32	51.27
Shares Change (YoY)	0%	0%	0%	-2%	-2%	-4%
EPS (Diluted)	325.1	385.69	328.58	44.71	316.22	272.2
EPS Growth	-5%	17%	635%	-86%	16%	0%
Free Cash Flow	976	-7,610	-31,112	-27,924	8,553	2,475
Free Cash Flow Per Share	19.82	-154.59	-632.09	-567.3	169.95	48.26
Gross Margin	36.25%	36.49%	35.7%	34.81%	42.37%	42.25%
Operating Margin	8.68%	8.95%	7.74%	2.64%	11.59%	12.86%
Profit Margin	6.1%	7.31%	7.09%	1.05%	9.6%	9.01%
Free Cash Flow Margin	0.37%	-2.93%	-13.64%	-13.36%	5.16%	1.59%
EBITDA	43,389	43,341	35,535	24,923	30,159	30,348
EBITDA Margin	16.54%	16.69%	15.59%	11.93%	18.21%	19.59%
D&A For EBITDA	20,613	20,099	17,888	19,409	10,954	10,425
EBIT	22,776	23,242	17,647	5,514	19,205	19,923
EBIT Margin	8.68%	8.95%	7.74%	2.64%	11.59%	12.86%
Effective Tax Rate	26.26%	27.88%	33.87%	52.2%	28.45%	25.46%

Towa Pharmaceutical Co Ltd (TWAPF) Price

TWAPF Stock Price Chart

TWAPF Income

Follow-Up Questions